StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2016, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Sun, 15 Nov 2015 18:46:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Mesoblast Lists On Nasdaq http://www.streetinsider.com/Press+Releases/Mesoblast+Lists+On+Nasdaq/11074749.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mesoblast+Lists+On+Nasdaq/11074749.html for the full story. http://www.streetinsider.com/Press+Releases/Mesoblast+Lists+On+Nasdaq/11074749.html Sun, 15 Nov 2015 18:46:00 -0400 A.10707735 MBLTY MESO MSB Mesoblast Lists On Nasdaq http://www.streetinsider.com/Press+Releases/Mesoblast+Lists+On+Nasdaq/11074749.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mesoblast+Lists+On+Nasdaq/11074749.html for the full story. http://www.streetinsider.com/Press+Releases/Mesoblast+Lists+On+Nasdaq/11074749.html Sun, 15 Nov 2015 18:46:00 -0400 A.10707735 MBLTY MESO MSB Mesoblast Lists On Nasdaq http://www.streetinsider.com/Press+Releases/Mesoblast+Lists+On+Nasdaq/11074749.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mesoblast+Lists+On+Nasdaq/11074749.html for the full story. http://www.streetinsider.com/Press+Releases/Mesoblast+Lists+On+Nasdaq/11074749.html Sun, 15 Nov 2015 18:46:00 -0400 A.10707735 MBLTY MESO MSB Mesoblast Lists On Nasdaq http://www.streetinsider.com/Press+Releases/Mesoblast+Lists+On+Nasdaq/11074749.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mesoblast+Lists+On+Nasdaq/11074749.html for the full story. http://www.streetinsider.com/Press+Releases/Mesoblast+Lists+On+Nasdaq/11074749.html Sun, 15 Nov 2015 18:46:00 -0400 A.10707735 MBLTY MESO MSB Mesoblast Announces Pricing Of Public Offering On Nasdaq http://www.streetinsider.com/Press+Releases/Mesoblast+Announces+Pricing+Of+Public+Offering+On+Nasdaq/11071231.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mesoblast+Announces+Pricing+Of+Public+Offering+On+Nasdaq/11071231.html for the full story. http://www.streetinsider.com/Press+Releases/Mesoblast+Announces+Pricing+Of+Public+Offering+On+Nasdaq/11071231.html Fri, 13 Nov 2015 08:38:00 -0400 A.10707735 MBLTY MESO MSB Mesoblast Announces Pricing Of Public Offering On Nasdaq http://www.streetinsider.com/Press+Releases/Mesoblast+Announces+Pricing+Of+Public+Offering+On+Nasdaq/11071231.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mesoblast+Announces+Pricing+Of+Public+Offering+On+Nasdaq/11071231.html for the full story. http://www.streetinsider.com/Press+Releases/Mesoblast+Announces+Pricing+Of+Public+Offering+On+Nasdaq/11071231.html Fri, 13 Nov 2015 08:38:00 -0400 A.10707735 MBLTY MESO MSB Mesoblast Announces Pricing Of Public Offering On Nasdaq http://www.streetinsider.com/Press+Releases/Mesoblast+Announces+Pricing+Of+Public+Offering+On+Nasdaq/11071231.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mesoblast+Announces+Pricing+Of+Public+Offering+On+Nasdaq/11071231.html for the full story. http://www.streetinsider.com/Press+Releases/Mesoblast+Announces+Pricing+Of+Public+Offering+On+Nasdaq/11071231.html Fri, 13 Nov 2015 08:38:00 -0400 A.10707735 MBLTY MESO MSB Mesoblast Announces Pricing Of Public Offering On Nasdaq http://www.streetinsider.com/Press+Releases/Mesoblast+Announces+Pricing+Of+Public+Offering+On+Nasdaq/11071231.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mesoblast+Announces+Pricing+Of+Public+Offering+On+Nasdaq/11071231.html for the full story. http://www.streetinsider.com/Press+Releases/Mesoblast+Announces+Pricing+Of+Public+Offering+On+Nasdaq/11071231.html Fri, 13 Nov 2015 08:38:00 -0400 A.10707735 MBLTY MESO MSB Key United States Patent Granted For The Treatment Of Heart Diseases, Stroke And Other Vascular Conditions http://www.streetinsider.com/Press+Releases/Key+United+States+Patent+Granted+For+The+Treatment+Of+Heart+Diseases%2C+Stroke+And+Other+Vascular+Conditions/11008024.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Key+United+States+Patent+Granted+For+The+Treatment+Of+Heart+Diseases%2C+Stroke+And+Other+Vascular+Conditions/11008024.html for the full story. http://www.streetinsider.com/Press+Releases/Key+United+States+Patent+Granted+For+The+Treatment+Of+Heart+Diseases%2C+Stroke+And+Other+Vascular+Conditions/11008024.html Tue, 27 Oct 2015 21:07:00 -0400 MSB MBLTY Key United States Patent Granted For The Treatment Of Heart Diseases, Stroke And Other Vascular Conditions http://www.streetinsider.com/Press+Releases/Key+United+States+Patent+Granted+For+The+Treatment+Of+Heart+Diseases%2C+Stroke+And+Other+Vascular+Conditions/11008024.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Key+United+States+Patent+Granted+For+The+Treatment+Of+Heart+Diseases%2C+Stroke+And+Other+Vascular+Conditions/11008024.html for the full story. http://www.streetinsider.com/Press+Releases/Key+United+States+Patent+Granted+For+The+Treatment+Of+Heart+Diseases%2C+Stroke+And+Other+Vascular+Conditions/11008024.html Tue, 27 Oct 2015 21:07:00 -0400 MSB MBLTY Mesoblast Chairman's Address to 2015 Annual General Meeting http://www.streetinsider.com/Press+Releases/Mesoblast+Chairman%26apos%3Bs+Address+to+2015+Annual+General+Meeting/10992154.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mesoblast+Chairman%26apos%3Bs+Address+to+2015+Annual+General+Meeting/10992154.html for the full story. http://www.streetinsider.com/Press+Releases/Mesoblast+Chairman%26apos%3Bs+Address+to+2015+Annual+General+Meeting/10992154.html Thu, 22 Oct 2015 02:00:00 -0400 MBLTY MSB Mesoblast Chairman's Address to 2015 Annual General Meeting http://www.streetinsider.com/Press+Releases/Mesoblast+Chairman%26apos%3Bs+Address+to+2015+Annual+General+Meeting/10992154.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Mesoblast+Chairman%26apos%3Bs+Address+to+2015+Annual+General+Meeting/10992154.html for the full story. http://www.streetinsider.com/Press+Releases/Mesoblast+Chairman%26apos%3Bs+Address+to+2015+Annual+General+Meeting/10992154.html Thu, 22 Oct 2015 02:00:00 -0400 MBLTY MSB Celgene and Mesoblast Extend Agreement http://www.streetinsider.com/Press+Releases/Celgene+and+Mesoblast+Extend+Agreement/10976996.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Celgene+and+Mesoblast+Extend+Agreement/10976996.html for the full story. http://www.streetinsider.com/Press+Releases/Celgene+and+Mesoblast+Extend+Agreement/10976996.html Thu, 15 Oct 2015 19:49:00 -0400 MSB MBLTY Celgene and Mesoblast Extend Agreement http://www.streetinsider.com/Press+Releases/Celgene+and+Mesoblast+Extend+Agreement/10976996.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Celgene+and+Mesoblast+Extend+Agreement/10976996.html for the full story. http://www.streetinsider.com/Press+Releases/Celgene+and+Mesoblast+Extend+Agreement/10976996.html Thu, 15 Oct 2015 19:49:00 -0400 MSB MBLTY Osiris Announces Initiation of a Phase III Trial for a New Investigational Drug, OTI-15-01, for the Treatment of Chronic Diabetic Foot Wounds http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html for the full story. http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html Tue, 06 Oct 2015 08:00:00 -0400 A.14320728 A.38925042 MBLTY MSB OSIR SYK Osiris Announces Initiation of a Phase III Trial for a New Investigational Drug, OTI-15-01, for the Treatment of Chronic Diabetic Foot Wounds http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html for the full story. http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html Tue, 06 Oct 2015 08:00:00 -0400 A.14320728 A.38925042 MBLTY MSB OSIR SYK Osiris Announces Initiation of a Phase III Trial for a New Investigational Drug, OTI-15-01, for the Treatment of Chronic Diabetic Foot Wounds http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html for the full story. http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html Tue, 06 Oct 2015 08:00:00 -0400 A.14320728 A.38925042 MBLTY MSB OSIR SYK Osiris Announces Initiation of a Phase III Trial for a New Investigational Drug, OTI-15-01, for the Treatment of Chronic Diabetic Foot Wounds http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html for the full story. http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html Tue, 06 Oct 2015 08:00:00 -0400 A.14320728 A.38925042 MBLTY MSB OSIR SYK Osiris Announces Initiation of a Phase III Trial for a New Investigational Drug, OTI-15-01, for the Treatment of Chronic Diabetic Foot Wounds http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html for the full story. http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html Tue, 06 Oct 2015 08:00:00 -0400 A.14320728 A.38925042 MBLTY MSB OSIR SYK Osiris Announces Initiation of a Phase III Trial for a New Investigational Drug, OTI-15-01, for the Treatment of Chronic Diabetic Foot Wounds http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html for the full story. http://www.streetinsider.com/Press+Releases/Osiris+Announces+Initiation+of+a+Phase+III+Trial+for+a+New+Investigational+Drug%2C+OTI-15-01%2C+for+the+Treatment+of+Chronic+Diabetic+Foot+Wounds/10949436.html Tue, 06 Oct 2015 08:00:00 -0400 A.14320728 A.38925042 MBLTY MSB OSIR SYK Phase 2 Trial Results Show Mesoblast Cell Therapy Has Greatest Cardioprotective Effect In Patients With Advanced Heart Failure http://www.streetinsider.com/Press+Releases/Phase+2+Trial+Results+Show+Mesoblast+Cell+Therapy+Has+Greatest+Cardioprotective+Effect+In+Patients+With+Advanced+Heart+Failure/10930244.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phase+2+Trial+Results+Show+Mesoblast+Cell+Therapy+Has+Greatest+Cardioprotective+Effect+In+Patients+With+Advanced+Heart+Failure/10930244.html for the full story. http://www.streetinsider.com/Press+Releases/Phase+2+Trial+Results+Show+Mesoblast+Cell+Therapy+Has+Greatest+Cardioprotective+Effect+In+Patients+With+Advanced+Heart+Failure/10930244.html Tue, 29 Sep 2015 21:10:00 -0400 A.11279008 A.30928927 MBLTY MSB Phase 2 Trial Results Show Mesoblast Cell Therapy Has Greatest Cardioprotective Effect In Patients With Advanced Heart Failure http://www.streetinsider.com/Press+Releases/Phase+2+Trial+Results+Show+Mesoblast+Cell+Therapy+Has+Greatest+Cardioprotective+Effect+In+Patients+With+Advanced+Heart+Failure/10930244.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phase+2+Trial+Results+Show+Mesoblast+Cell+Therapy+Has+Greatest+Cardioprotective+Effect+In+Patients+With+Advanced+Heart+Failure/10930244.html for the full story. http://www.streetinsider.com/Press+Releases/Phase+2+Trial+Results+Show+Mesoblast+Cell+Therapy+Has+Greatest+Cardioprotective+Effect+In+Patients+With+Advanced+Heart+Failure/10930244.html Tue, 29 Sep 2015 21:10:00 -0400 A.11279008 A.30928927 MBLTY MSB Phase 2 Trial Results Show Mesoblast Cell Therapy Has Greatest Cardioprotective Effect In Patients With Advanced Heart Failure http://www.streetinsider.com/Press+Releases/Phase+2+Trial+Results+Show+Mesoblast+Cell+Therapy+Has+Greatest+Cardioprotective+Effect+In+Patients+With+Advanced+Heart+Failure/10930244.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phase+2+Trial+Results+Show+Mesoblast+Cell+Therapy+Has+Greatest+Cardioprotective+Effect+In+Patients+With+Advanced+Heart+Failure/10930244.html for the full story. http://www.streetinsider.com/Press+Releases/Phase+2+Trial+Results+Show+Mesoblast+Cell+Therapy+Has+Greatest+Cardioprotective+Effect+In+Patients+With+Advanced+Heart+Failure/10930244.html Tue, 29 Sep 2015 21:10:00 -0400 A.11279008 A.30928927 MBLTY MSB Phase 2 Trial Results Show Mesoblast Cell Therapy Has Greatest Cardioprotective Effect In Patients With Advanced Heart Failure http://www.streetinsider.com/Press+Releases/Phase+2+Trial+Results+Show+Mesoblast+Cell+Therapy+Has+Greatest+Cardioprotective+Effect+In+Patients+With+Advanced+Heart+Failure/10930244.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Phase+2+Trial+Results+Show+Mesoblast+Cell+Therapy+Has+Greatest+Cardioprotective+Effect+In+Patients+With+Advanced+Heart+Failure/10930244.html for the full story. http://www.streetinsider.com/Press+Releases/Phase+2+Trial+Results+Show+Mesoblast+Cell+Therapy+Has+Greatest+Cardioprotective+Effect+In+Patients+With+Advanced+Heart+Failure/10930244.html Tue, 29 Sep 2015 21:10:00 -0400 A.11279008 A.30928927 MBLTY MSB Full Product Approval In Japan Received By Mesoblast Licensee http://www.streetinsider.com/Press+Releases/Full+Product+Approval+In+Japan+Received+By+Mesoblast+Licensee/10903141.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Full+Product+Approval+In+Japan+Received+By+Mesoblast+Licensee/10903141.html for the full story. http://www.streetinsider.com/Press+Releases/Full+Product+Approval+In+Japan+Received+By+Mesoblast+Licensee/10903141.html Fri, 18 Sep 2015 01:23:00 -0400 MBLTY MSB